ERK inhibitor XMD 17-109, Purity ≥98%

Synonym: XMD17-109; 1435488-37-1; 11-Cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one; XMD17109; 11-Cyclopentyl-2-((2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)phenyl)amino)-5-methyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one; ERK inhibitor

CAS Number: 1435488-37-1
Compound CID: 71604307

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

XMD 17-109, soluble in DMSO and ethanol and insoluble in water, exhibits potent inhibition of ERK kinase. It targets ERK5.

Molecular Weight

638.8

Molecular Formula

C₃₆H₄₆N₈O₃

Targets

ERK5: 162 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 97 mg/mL (151.84 mM); Water: Insoluble; Ethanol: 97 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

XMD 17-109 can be applied to the study of ERK1/2 inhibition in cancer biology and therapy.

Storage

Store at -20ºC.